Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05340855
Other study ID # 22-000477
Secondary ID UG1DA040316-07S3
Status Completed
Phase N/A
First received
Last updated
Start date May 5, 2022
Est. completion date June 8, 2023

Study information

Verified date May 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to develop a culturally relevant Facebook intervention for American Indian and Alaska Native (AIAN) women in Minnesota recovering from illicit opioid use.


Description:

This one-year, Phase I, pilot preparatory study aims to develop a culturally relevant Facebook intervention for American Indian and Alaska Native (AIAN) women in Minnesota recovering from illicit opioid use. The study will consist of three phases: (1) qualitative interviews, (2) intervention content refinement and a moderator exchange (i.e., bi-directional sharing of knowledge between intervention moderators and trainers), and (3) a beta-testing period. A study-specific Community Advisory Committee (CAC) was formed whose members contributed to the study protocol and will continue to provide guidance and input on the study implementation and dissemination. At the advice of the CAC, a Native Elder woman named the study. Wiidookaage'win is an Ojibwe word that means "the place for help and time for helping," and reflects healing and community. The investigators expect the participatory approach to treatment development will result in a social media intervention with cultural relevance for Native women to maintain recovery from opioid use.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date June 8, 2023
Est. primary completion date June 8, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria - Phase 1: AIAN Women: - AIAN based on self-reported race. - Gender identity as a woman. - Resides in Minnesota. - At least 18 years of age age with no upper age limit. - OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013). - Self-reports at least one month of opioid abstinence based on Timeline Follow-Back (TLFB) interview. - Currently receiving MOUD. - Is comfortable speaking and reading English. - Is familiar with Facebook. - Has access to broadband internet on a mobile phone/computer/tablet at any location. AI/AN Health Care Providers and Stakeholders - Health care provider or AIAN community stakeholder. - Knowledge of Native culture and/or OUD treatment and recovery among AIAN people. - Is comfortable speaking and reading English. - Is familiar with Facebook. - Has access to broadband internet on a mobile phone/computer/tablet at any location. Having some familiarity with the Facebook platform is needed to provide feedback on content for a Facebook intervention. Access to the internet is needed to view online moderator postings for providing feedback during the interview. Inclusion Criteria - Phase 3: - AIAN person based on self-reported race/ethnicity. - Gender identity as a woman. - At least 18 years of age. - Resides in Minnesota. - OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013). - Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen. - Currently receiving MOUD. - Is comfortable speaking and reading English. - Has an existing Facebook account or willing to set one up. - Is willing and able to participate in the Facebook intervention for one month. - Has access to broadband internet on a mobile phone/computer/tablet at any location. - Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS. Exclusion Criteria: AIAN potential participants in Phases 1 and 3 meeting any of the exclusion criteria listed below will be excluded from study participation. Community stakeholder participants in - Phase 1 will only fail the screening if they meet the second exclusion criterion: - Self-reports current suicidality. - Inability or unwillingness of participant to provide verbal consent (Phase 1) or written informed consent (Phase 3). - (Phase 3 only) Was a participant in Phase 1. Pregnant women, lactating women, or women who plan to become pregnant will not be excluded because the treatment being evaluated is a behavioral intervention and does not involve medication or risk to the fetus.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Wiidookaage'win Facebook Group
A 30-day Facebook group prototype that is moderated by two women who will post various forms of media addressing opioid recovery, mindfulness, stress management, and resiliency.

Locations

Country Name City State
United States Mayo Clinic Rochester Rochester Minnesota

Sponsors (2)

Lead Sponsor Collaborator
Mayo Clinic National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Young A, Sinicrope P, Kelpin S, Roche AI, Sabaque C, Pham C, Marsch LA, Campbell ANC, Venner K, Bastian E, Nord T, Mason G, Baker L, Wyatt T, Fish A, Bart G, Patten CA. Wiidookaage'Win: A Community-Based Qualitative Approach to Developing a Facebook Group Intervention for Native Women to Support Recovery From Opioid Use. Am J Health Promot. 2024 Feb;38(2):205-218. doi: 10.1177/08901171231205355. Epub 2023 Nov 13. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The Feasibility of Developing a Culturally Relevant Facebook Intervention The number of times participants engaged with the Facebook page. Define by the total times of viewing, reacting, posting, commenting and voting on any Facebook post for all participants. 30 days
Secondary The Feasibility of Using Facebook as an Opioid Intervention Platform The number of participants who completed all study activities from baseline to end of study. 30 days
Secondary Treatment Satisfaction Treatment Satisfaction was measured using a 5-point Likert scale (1 = Strongly disagree, 5 = Strongly agree). Total scores range from 1 -5. Higher scores indicate greater satisfaction and lower scores indicate lower satisfaction. 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT04095624 - Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion N/A
Completed NCT04484610 - Appropriate Opioid Quantities for Acute Pain - Pharmacist Study Phase 4
Recruiting NCT04598074 - Opioid Package Prototype (OPP) N/A
Recruiting NCT06033599 - Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement Phase 3
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Completed NCT05845177 - Persistent Pain After Hip Replacement
Completed NCT03570320 - Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries? N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT05593341 - Opioid Education in Total Knee Arthroplasty N/A
Recruiting NCT06055205 - A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries N/A
Recruiting NCT05877157 - Pain AND Opioids After Surgery
Recruiting NCT03675386 - Reducing Opioid Use for Chronic Pain Patients Following Surgery N/A
Suspended NCT05001789 - Cognitive Functioning in Opioid Use Disorder N/A
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT04868552 - Naloxone Education in Total Joint Patients N/A
Completed NCT03540030 - Opioid-Free Shoulder Arthroplasty Phase 4
Terminated NCT06217380 - Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program N/A
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2
Terminated NCT03426137 - Relieving Acute Pain (RAP) Study: A Pilot Study Phase 2

External Links